Issues for DSM-V: psychological factors affecting either identified or feared medical conditions: a solution for somatoform disorders.

PubWeight™: 0.83‹?›

🔗 View Article (PMID 17606648)

Published in Am J Psychiatry on July 01, 2007

Authors

Giovanni A Fava, Thomas N Wise

Articles by these authors

Long-term treatment with antidepressant drugs: the spectacular achievements of propaganda. Psychother Psychosom (2002) 2.11

The biopsychosocial model thirty years later. Psychother Psychosom (2007) 1.68

Persistent psychological distress in patients treated for endocrine disease. Psychother Psychosom (2004) 1.51

Excessive mood elevation and behavioral activation with antidepressant treatment of juvenile depressive and anxiety disorders: a systematic review. Psychother Psychosom (2013) 1.50

Mood and anxiety disorders as early manifestations of medical illness: a systematic review. Psychother Psychosom (2014) 1.46

Pedophilia. JAMA (2002) 1.43

Is depression the wrong treatment target for improving outcome in coronary artery disease? Psychother Psychosom (2013) 1.43

Core competencies for fellowship training in psychosomatic medicine: a collaborative effort by the APA Council on Psychosomatic Medicine, the ABPN Psychosomatic Committee, and the Academy of Psychosomatic Medicine. Psychosomatics (2009) 1.39

The changing content of Psychosomatics: reflection of the growth of consultation-liaison psychiatry? Psychosomatics (2004) 1.39

Unmasking special interest groups: the key to addressing conflicts of interest in medicine. Psychother Psychosom (2010) 1.38

The biopsychosocial factor. Psychother Psychosom (2011) 1.38

The concept of recovery in major depression. Psychol Med (2007) 1.27

The cult of mediocrity. Psychother Psychosom (2005) 1.15

Assessing demoralization and depression in the setting of medical disease. J Clin Psychiatry (2005) 1.03

Staging of mental disorders: systematic review. Psychother Psychosom (2012) 0.98

Well-being therapy in school settings: a pilot study. Psychother Psychosom (2006) 0.97

Role of well-being therapy in achieving a balanced and individualized path to optimal functioning. Clin Psychol Psychother (2012) 0.97

Cognitive performance enhancement: misuse or self-treatment? J Atten Disord (2010) 0.96

Agoraphobia: a review of the diagnostic classificatory position and criteria. Depress Anxiety (2010) 0.94

Mania associated with venlafaxine discontinuation. Int J Neuropsychopharmacol (2003) 0.94

Psychosomatic aspects of Cushing's syndrome. Rev Endocr Metab Disord (2010) 0.93

School intervention for promoting psychological well-being in adolescence. J Behav Ther Exp Psychiatry (2009) 0.91

Psychosocial impairment in patients treated for pituitary disease: a controlled study. Clin Endocrinol (Oxf) (2007) 0.91

Well-being therapy for generalized anxiety disorder. J Clin Psychol (2009) 0.91

The Illness Attitude Scales. A clinimetric index for assessing hypochondriacal fears and beliefs. Psychother Psychosom (2008) 0.90

Information overload, the patient and the clinician. Psychother Psychosom (2007) 0.90

Psychological factors affecting medical condition: a new proposal for DSM-V. Psychosomatics (2007) 0.89

New strategies in the assessment of psychological factors affecting medical conditions. J Pers Assess (2007) 0.88

Increased risk of suicide among patients with breast implants: do the epidemiologic data support psychiatric consultation? Psychosomatics (2004) 0.88

The relationship of psychological well-being to distress and personality. Psychother Psychosom (2003) 0.88

A different medicine is possible. Psychother Psychosom (2006) 0.87

Effects of progressive muscle relaxation training on anxiety and depression in patients enrolled in an outpatient pulmonary rehabilitation program. Psychother Psychosom (2008) 0.87

The unifying concept of illness behavior. Psychother Psychosom (2012) 0.86

Cardiovascular health and depression. J Psychiatr Pract (2003) 0.86

Psychosomatic assessment of skin diseases in clinical practice. Psychother Psychosom (2005) 0.85

Psychosomatic characterization of adjustment disorders in the medical setting: some suggestions for DSM-V. J Affect Disord (2006) 0.84

Circadian blood pressure patterns and life stress. Psychother Psychosom (2002) 0.84

Psychological aspects of primary aldosteronism. Psychother Psychosom (2006) 0.84

Managing the neuropsychiatric side effects of interferon-based therapy for hepatitis C. Cleve Clin J Med (2004) 0.83

Alexithymia and emotional intelligence in patients with panic disorder, generalized anxiety disorder and major depressive disorder. Psychiatr Q (2013) 0.83

Subtyping depression in the medically ill by cluster analysis. J Affect Disord (2011) 0.83

Psychological assessment of primary aldosteronism: a controlled study. J Clin Endocrinol Metab (2011) 0.81

Treatment selection in depression: the role of clinical judgment. Psychiatr Clin North Am (2012) 0.81

How citation analysis can monitor the progress of research in clinical medicine. Psychother Psychosom (2004) 0.81

Anger experiences among hepatitis C patients: relationship to depressive symptoms and health-related quality of life. Psychosomatics (2007) 0.81

Protective environments and health status: cross-talk between human and animal studies. Neurobiol Aging (2005) 0.81

Neuroleptic malignant syndrome after exposure to asenapine: a case report. Prim Care Companion J Clin Psychiatry (2010) 0.81

Personality characteristics and quality of life in patients treated for Cushing's syndrome. Clin Endocrinol (Oxf) (2006) 0.81

Psychological assessment in cardiac rehabilitation. Psychother Psychosom (2003) 0.81

Assessing the community prevalence of bipolar spectrum symptoms by the mood disorder questionnaire. Psychother Psychosom (2005) 0.80

Diagnostic criteria for psychosomatic research are necessary for DSM V. Psychother Psychosom (2009) 0.80

Differential effects of well-being promoting and anxiety-management strategies in a non-clinical school setting. J Anxiety Disord (2010) 0.79

Psychological characterization of demoralization in the setting of heart transplantation. J Clin Psychiatry (2010) 0.79

Diagnostic criteria for psychosomatic research and somatic symptom disorders. Int Rev Psychiatry (2013) 0.79

The clinical factor. Psychother Psychosom (2010) 0.79

The need for a behavioural science focus in research on mental health and mental disorders. Int J Methods Psychiatr Res (2014) 0.78

Irritable mood in Italian patients with medical disease. J Nerv Ment Dis (2006) 0.78

The somatoform disorders for DSM-V: the need for changes in process and content. Psychosomatics (2002) 0.78

The Safety, Tolerability and Risks Associated with the Use of Newer Generation Antidepressant Drugs: A Critical Review of the Literature. Psychother Psychosom (2016) 0.78

Conflict of interest in psychopharmacology: can Dr. Jekyll still control Mr. Hyde? Psychother Psychosom (2003) 0.78

Interface of Women's Mental and Reproductive Health. Curr Psychiatry Rep (2005) 0.78

The Clinical Interview for Depression: a comprehensive review of studies and clinimetric properties. Psychother Psychosom (2010) 0.77

Family intervention approach to loss of clinical effect during long-term antidepressant treatment: a pilot study. J Clin Psychiatry (2007) 0.77

Use of the Diagnostic Criteria for Psychosomatic Research (DCPR) in a community sample. Psychosomatics (2006) 0.77

Principles of psychosomatic assessment. Adv Psychosom Med (2011) 0.77

Residual symptoms in depression an emerging therapeutic concept. Prog Neuropsychopharmacol Biol Psychiatry (2002) 0.77

Kellner's emotional inhibition scale: a clinimetric approach to alexithymia research. Psychother Psychosom (2011) 0.77

Psychosocial approach to endocrine disease. Adv Psychosom Med (2007) 0.77

Improving the concept of recovery in endocrine disease by consideration of psychosocial issues. J Clin Endocrinol Metab (2012) 0.76

Development of a new assessment strategy in psychosomatic medicine: the diagnostic criteria for psychosomatic research. Adv Psychosom Med (2007) 0.76

Assessing somatization with various diagnostic criteria. Psychosomatics (2009) 0.76

Rehabilitation in endocrine patients: a novel psychosomatic approach. Psychother Psychosom (2007) 0.76

Assessing psychological factors affecting medical conditions: comparison between different proposals. Gen Hosp Psychiatry (2012) 0.76

Curiosity and crisis. Psychother Psychosom (2006) 0.76

Modern psychiatric treatment: a tribute to Thomas Detre, MD (1924-2011). Psychother Psychosom (2012) 0.76

Clinical Methodology Matters in Epidemiology: Not All Benzodiazepines Are the Same. Psychother Psychosom (2015) 0.75

Panic and depression. Am J Psychiatry (2002) 0.75

How long should drug treatment of depression last? Med J Aust (2003) 0.75

A revised Emotional Intelligence Scale: factor re-evaluation and item reduction. Psychol Rep (2006) 0.75

A Prescient View of Palliative Care by the Psychiatric Physician. Psychiatry (2016) 0.75

General and specialized medicine and psychiatry. Adv Psychosom Med (2012) 0.75

Split gender identity: problem or solution? Proposed parameters for addressing the gender dysphoric patient. J Sex Marital Ther (2002) 0.75

Alternatives to debriefing and modifications to cognitive behavior therapy for posttraumatic stress disorder. Psychother Psychosom (2005) 0.75

Physician staffing for the practice of psychosomatic medicine in general hospitals: a pilot study. Psychosomatics (2010) 0.75

[Therapeutic factors in depression: new strategies]. Riv Psichiatr (2010) 0.75

Preserving intellectual freedom in clinical medicine. Psychother Psychosom (2008) 0.75

[What are the differences between well-being therapy and anxiety management in the school setting?]. Riv Psichiatr (2011) 0.75

Psychosomatic medicine: a name to keep. Psychother Psychosom (2009) 0.75

Conflict of interest and the credibility of medical journals. Epidemiol Psichiatr Soc (2003) 0.75

Response to "An Evolutionary Approach to Clinical Pharmacopsychology". Psychother Psychosom (2017) 0.75

Erratum to "CNS drugs in Cushing's disease: pathophysiological and therapeutic implications for mood disorders" [Prog. Neuro-Psycol. Biol. Psychiatry, 26, 763 (2002)]. Prog Neuropsychopharmacol Biol Psychiatry (2002) 0.75

Statistical alchemy for drug treatment of generalized anxiety disorder: a commentary on the meta-analysis by Baldwin et al. [BMJ 2011;342:d1199]. Psychother Psychosom (2011) 0.75

Update on diagnoses of sexual dysfunctions: controversies surrounding the proposed revisions of existing diagnostic entities and proposed new diagnoses. Adv Psychosom Med (2011) 0.75

Integration of multiple criteria for psychosomatic assessment of dermatological patients. Psychosomatics (2006) 0.75

Psychiatric classification in the setting of medical disease: comparing the clinical value of different proposals. J Psychosom Res (2010) 0.75